Literature DB >> 1554489

Serum resistance in Escherichia coli strains causing acute pyelonephritis and bacteraemia.

S H Jacobson1, C G Ostenson, K Tullus, A Brauner.   

Abstract

The capacity of Escherichia coli to resist the bactericidal action of serum was examined in 367 clinical isolates obtained from children with acute pyelonephritis (n = 57), adults with acute pyelonephritis (n = 55), non-diabetic patients with bacteraemia (n = 101), diabetic patients with bacteraemia (n = 65) and from the faecal flora of healthy controls (n = 89). The incidence of serum-resistant E. coli strains was significantly higher in pyelonephritogenic strains from children and adults (93% and 82%) as compared to faecal control strains (57%, p less than 0.001 and p less than 0.005 respectively). Strains causing bacteraemia in non-diabetic and diabetic patients were more often serum resistant (72% and 80%) as compared to control strains (p less than 0.05 and p less than 0.001 respectively). The frequency of serum-sensitive strains was similar in diabetic patients with decreased renal function or proteinuria compared to those with normal renal function. There were no significant correlations between serum resistance of E. coli and expression of P fimbriae, type I fimbriae or mannose-resistant haemagglutination, cell surface hydrophobic properties, production of aerobactin, haemolysin or cytotoxic necrotizing factor in 53 pyelonephritogenic strains from adult patients.

Entities:  

Mesh:

Year:  1992        PMID: 1554489

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

Review 1.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Cholangitis: bacterial virulence factors that facilitate cholangiovenous reflux and tumor necrosis factor-alpha production.

Authors:  Lygia Stewart; Adair L Oesterle; J McLeod Grifiss; Gary A Jarvis; Lawrence W Way
Journal:  J Gastrointest Surg       Date:  2003-02       Impact factor: 3.452

3.  Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs.

Authors:  Natalie M Mitchell; James R Johnson; Brian Johnston; Roy Curtiss; Melha Mellata
Journal:  Appl Environ Microbiol       Date:  2014-12-05       Impact factor: 4.792

4.  Serum response of Escherichia coli strains causing dyspepsia and urinary tract infection: relation to alpha-hemolysin production and O type.

Authors:  L Siegfried; M Kmetová; V Janigová; M Sasinka; V Takácová
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.

Authors:  C Capodici; S Chen; Z Sidorczyk; P Elsbach; J Weiss
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

6.  A Novel Method of Serum Resistance by Escherichia coli That Causes Urosepsis.

Authors:  Carrie F Coggon; Andrew Jiang; Kelvin G K Goh; Ian R Henderson; Mark A Schembri; Timothy J Wells
Journal:  mBio       Date:  2018-06-26       Impact factor: 7.867

7.  The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.

Authors:  Minh-Duy Phan; Kate M Peters; Sohinee Sarkar; Samuel W Lukowski; Luke P Allsopp; Danilo Gomes Moriel; Maud E S Achard; Makrina Totsika; Vikki M Marshall; Mathew Upton; Scott A Beatson; Mark A Schembri
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

8.  An alternative approach for evaluating the phenotypic virulence factors of pathogenic Escherichia coli.

Authors:  Kamelia M Osman; Ashgan M Hessain; Usama H Abo-Shama; Zeinab M Girh; Saleh A Kabli; Hassan A Hemeg; Ihab M Moussa
Journal:  Saudi J Biol Sci       Date:  2017-05-03       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.